المؤلفون: Andrea Casadei-Gardini, Margherita Rimini, Yeonghak Bang, Caterina Vivaldi, Min-Hee Ryoo, Mario Domenico Rizzato, Francesca Bergamo, Alessandro Granito, Francesca Salani, Luca Ielasi, Valentina Burgio, Hyung-Don Kim, Simona Leoni, Sara Lonardi, Gianluca Masi, Stefano Cascinu, Changhoon Yoo, Baek-Yeol Ryoo

المساهمون: Rimini, M., Yoo, C., Lonardi, S., Masi, G., Granito, A., Bang, Y., Rizzato, M. D., Vivaldi, C., Ielasi, L., Kim, H. -D., Bergamo, F., Salani, F., Leoni, S., Ryoo, B. -Y., Ryoo, M. -H., Burgio, V., Cascinu, S., Casadei-Gardini, A., Rimini M., Yoo C., Lonardi S., Masi G., Granito A., Bang Y., Rizzato M.D., Vivaldi C., Ielasi L., Kim H.-D., Bergamo F., Salani F., Leoni S., Ryoo B.-Y., Ryoo M.-H., Burgio V., Cascinu S., Casadei-Gardini A.

مصطلحات موضوعية: Phenylurea Compound, Sorafenib, Oncology, Cancer Research, medicine.medical_specialty, Carcinoma, Hepatocellular, Prognosi, Pyridines, Pyridine, Population, Recursive partitioning, chemistry.chemical_compound, Regorafenib, Internal medicine, medicine, Humans, Pharmacology (medical), education, Univariate analysis, education.field_of_study, business.industry, Phenylurea Compounds, Liver Neoplasms, medicine.disease, Prognosis, Confidence interval, chemistry, Hepatocellular carcinoma, Cohort, business, Human, medicine.drug

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cfc7d916296dd1c3014b94162795ef9Test
http://hdl.handle.net/11568/1106994Test

المؤلفون: Andrea Casadei‐Gardini, Mario Scartozzi, Toshifumi Tada, Changhoon Yoo, Shigeo Shimose, Gianluca Masi, Sara Lonardi, Luca Giovanni Frassineti, Silvestris Nicola, Fabio Piscaglia, Takashi Kumada, Hyung‐Don Kim, Hironori Koga, Caterina Vivaldi, Caterina Soldà, Atsushi Hiraoka, Yeonghak Bang, Masanori Atsukawa, Takuji Torimura, Kunihiko Tsuj, Ei Itobayashi, Hidenori Toyoda, Shinya Fukunishi, Lorenza Rimassa, Margherita Rimini, Stefano Cascinu, Alessandro Cucchetti, Shinichiro Nakamura, Kojiro Michitaka, Norio Itokawa, Korenobu Hayama, Masashi Hirooka, Yohei Koizumi, Yoichi Hiasa, Toru Ishikawa, Michitaka Imai, Koichi Takaguchi, Akemi Tsutsui, Takuya Nagano, Kazuya Kariyama, Kazuhiro Nouso, Kazuto Tajiri, Noritomo Shimada, Hiroshi Shibata, Hironori Ochi, Kouji Joko, Satoshi Yasuda, Hideko Ohama, Kazuhito Kawata

المساهمون: Casadei-Gardini A., Scartozzi M., Tada T., Yoo C., Shimose S., Masi G., Lonardi S., Frassineti L.G., Nicola S., Piscaglia F., Kumada T., Kim H.-D., Koga H., Vivaldi C., Solda C., Hiraoka A., Bang Y., Atsukawa M., Torimura T., Tsuj K., Itobayashi E., Toyoda H., Fukunishi S., Rimassa L., Rimini M., Cascinu S., Cucchetti A., Nakamura S., Michitaka K., Itokawa N., Hayama K., Hirooka M., Koizumi Y., Hiasa Y., Ishikawa T., Imai M., Takaguchi K., Tsutsui A., Nagano T., Kariyama K., Nouso K., Tajiri K., Shimada N., Shibata H., Ochi H., Joko K., Yasuda S., Ohama H., Kawata K., Casadei-Gardini, A., Scartozzi, M., Tada, T., Yoo, C., Shimose, S., Masi, G., Lonardi, S., Frassineti, L. G., Nicola, S., Piscaglia, F., Kumada, T., Kim, H. -D., Koga, H., Vivaldi, C., Solda, C., Hiraoka, A., Bang, Y., Atsukawa, M., Torimura, T., Tsuj, K., Itobayashi, E., Toyoda, H., Fukunishi, S., Rimassa, L., Rimini, M., Cascinu, S., Cucchetti, A., Nakamura, S., Michitaka, K., Itokawa, N., Hayama, K., Hirooka, M., Koizumi, Y., Hiasa, Y., Ishikawa, T., Imai, M., Takaguchi, K., Tsutsui, A., Nagano, T., Kariyama, K., Nouso, K., Tajiri, K., Shimada, N., Shibata, H., Ochi, H., Joko, K., Yasuda, S., Ohama, H., Kawata, K.

مصطلحات موضوعية: Sorafenib, Oncology, medicine.medical_specialty, Carcinoma, Hepatocellular, Antineoplastic Agents, lenvatinib, survival, trans-arterial chemoembolization, law.invention, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, medicine, Clinical endpoint, performance status, Humans, Adverse effect, Probability, Hepatology, Performance status, business.industry, Phenylurea Compounds, Carcinoma, Liver Neoplasms, Hepatocellular, medicine.disease, extrahepatic disease, sorafenib, Quinolines, chemistry, 030220 oncology & carcinogenesis, Hepatocellular carcinoma, Cohort, 030211 gastroenterology & hepatology, Lenvatinib, business, medicine.drug, performance statu

وصف الملف: ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb1525de64e54068b735c079325a057eTest
http://hdl.handle.net/11568/1111033Test

المؤلفون: Fabio Piscaglia, Irene Pecora, Luca Ielasi, Giulia Rovesti, Vittorina Zagonel, Vincenzo Dadduzio, Mario Domenico Rizzato, Alessandro Granito, Francesca Benevento, Giorgia Marisi, Oronzo Brunetti, Francesco Tovoli, Fabio Conti, Federica Teglia, Giuseppe Cabibbo, Giulia Orsi, Mario Scartozzi, Andrea Casadei-Gardini, Alessandro Cucchetti, Francesco Giuseppe Foschi, Laura Gramantieri, Francesca Salani, Stefano Cascinu, Sara Lonardi, Antonella Argentiero, Caterina Vivaldi

المساهمون: Orsi, G., Tovoli, F., Dadduzio, V., Vivaldi, C., Brunetti, O., Ielasi, L., Conti, F., Rovesti, G., Gramantieri, L., Rizzato, M. D., Pecora, I., Argentiero, A., Teglia, F., Lonardi, S., Salani, F., Granito, A., Zagonel, V., Marisi, G., Cabibbo, G., Foschi, F. G., Benevento, F., Cucchetti, A., Piscaglia, F., Cascinu, S., Scartozzi, M., Casadei-Gardini, A., Orsi G., Tovoli F., Dadduzio V., Vivaldi C., Brunetti O., Ielasi L., Conti F., Rovesti G., Gramantieri L., Rizzato M.D., Pecora I., Argentiero A., Teglia F., Lonardi S., Salani F., Granito A., Zagonel V., Marisi G., Cabibbo G., Foschi F.G., Benevento F., Cucchetti A., Piscaglia F., Cascinu S., Scartozzi M., Casadei-Gardini A., Orsi, Giulia, Tovoli, Francesco, Dadduzio, Vincenzo, Vivaldi, Caterina, Brunetti, Oronzo, Ielasi, Luca, Conti, Fabio, Rovesti, Giulia, Gramantieri, Laura, Rizzato, Mario Domenico, Pecora, Irene, Argentiero, Antonella, Teglia, Federica, Lonardi, Sara, Salani, Francesca, Granito, Alessandro, Zagonel, Vittorina, Marisi, Giorgia, Cabibbo, Giuseppe, Foschi, Francesco Giuseppe, Benevento, Francesca, Cucchetti, Alessandro, Piscaglia, Fabio, Cascinu, Stefano, Scartozzi, Mario, Casadei-Gardini, Andrea

المصدر: Targeted oncology. 15(6)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Sorafenib, Adult, Male, Cancer Research, medicine.medical_specialty, Multivariate analysis, Carcinoma, Hepatocellular, Inflammation, Aged, Aged, 80 and over, Eosinophils, Female, Humans, Liver Neoplasms, Middle Aged, Prognosis, Survival Analysis, Young Adult, Capecitabine, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, Regorafenib, 80 and over, medicine, Pharmacology (medical), Settore MED/12 - Gastroenterologia, business.industry, Carcinoma, Hepatocellular, hepatocellular carcinoma, Eosinophil, medicine.disease, Confidence interval, 030104 developmental biology, medicine.anatomical_structure, chemistry, 030220 oncology & carcinogenesis, Hepatocellular carcinoma, medicine.symptom, business, medicine.drug

وصف الملف: ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e545905fba8fa824cc7ea1f0218071d5Test
https://pubmed.ncbi.nlm.nih.gov/33113041Test

المؤلفون: Giuseppe Aprile, Anne-Laure Pointet, Mario Scartozzi, Astrid Lièvre, David Tougeron, Ludovic Evesque, Angélique Vienot, Sara Lonardi, Samuel Le Sourd, Bertrand Brieau, Nicola Silvestris, Dewi Vernerey, Laetitia Dahan, Gico Investigators, Benoit Rousseau, Cindy Neuzillet, Aurélia Meurisse, Giovanni Brandi, Caterina Vivaldi, Andrea Casadei-Gardini, Ageo investigators, Roberto Filippi

المساهمون: Institut Curie [Paris], Université de Versailles Saint-Quentin-en-Yvelines - UFR Sciences de la santé Simone Veil (UVSQ Santé), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Università degli Studi di Modena e Reggio Emilia = University of Modena and Reggio Emilia (UNIMORE), Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), University of Pisa - Università di Pisa, Policlinico S. Orsola-malpighi, Alma Mater Studiorum Università di Bologna [Bologna] (UNIBO)-Servizio sanitario regionale Emilia-Romagna, Centre hospitalier universitaire de Poitiers (CHU Poitiers), Università degli studi di Torino = University of Turin (UNITO), Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), Università degli studi di Bari Aldo Moro = University of Bari Aldo Moro (UNIBA), Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), CHU Henri Mondor [Créteil], Università degli Studi di Cagliari = University of Cagliari (UniCa), Hôpital de la Timone [CHU - APHM] (TIMONE), Università degli Studi di Udine - University of Udine [Italie], CRLCC Eugène Marquis (CRLCC), Centre de Lutte contre le Cancer Antoine Lacassagne [Nice] (UNICANCER/CAL), UNICANCER-Université Côte d'Azur (UCA), Chemistry, Oncogenesis, Stress and Signaling (COSS), Université de Rennes (UR)-CRLCC Eugène Marquis (CRLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Neuzillet, C., Casadei Gardini, A., Brieau, B., Vivaldi, C., Brandi, G., Tougeron, D., Filippi, R., Vienot, A., Silvestris, N., Pointet, A. -L., Lonardi, S., Rousseau, B., Scartozzi, M., Dahan, L., Aprile, G., Le Sourd, S., Evesque, L., Meurisse, A., Lievre, A., Vernerey, D., CHU Henri Mondor, Jonchère, Laurent, Neuzillet C., Casadei-Gardini A., Brieau B., Vivaldi C., Brandi G., Tougeron D., Filippi R., Vienot A., Silvestris N., Pointet A.-L., Lonardi S., Rousseau B., Scartozzi M., Dahan L., Aprile G., Le Sourd S., Evesque L., Meurisse A., Lievre A., Vernerey D., Università degli Studi di Modena e Reggio Emilia, Università degli studi di Torino (UNITO), Università degli studi di Bari Aldo Moro (UNIBA), Universita degli Studi di Cagliari [Cagliari], Université Côte d'Azur (UCA)-UNICANCER, Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-CRLCC Eugène Marquis (CRLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)

المصدر: International Journal of Cancer
International Journal of Cancer, 2020, 147 (11), pp.3177-3188. ⟨10.1002/ijc.33146⟩
International Journal of Cancer, Wiley, 2020, 147 (11), pp.3177-3188. ⟨10.1002/ijc.33146⟩

مصطلحات موضوعية: Oncology, Male, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, overall survival, [SDV.CAN]Life Sciences [q-bio]/Cancer, Irinotecan, cholangiocarcinoma, combination chemotherapy, monotherapy, palliative chemotherapy, Aged, Antineoplastic Combined Chemotherapy Protocols, Bile Duct Neoplasms, Capecitabine, Female, Fluorouracil, France, Humans, Italy, Middle Aged, Platinum, Prospective Studies, Pyrimidines, Retrospective Studies, Survival Analysis, Treatment Outcome, 03 medical and health sciences, 0302 clinical medicine, [SDV.CAN] Life Sciences [q-bio]/Cancer, Internal medicine, medicine, Chemotherapy, Performance status, business.industry, Combination chemotherapy, cholangiocarcinoma, combination chemotherapy, monotherapy, overall survival, palliative chemotherapy, Gemcitabine, 3. Good health, Oxaliplatin, Regimen, 030220 oncology & carcinogenesis, Cohort, business, medicine.drug

وصف الملف: application/pdf; STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0845ac06765b2fd49c595f624a1cf498Test
https://pubmed.ncbi.nlm.nih.gov/32525595Test

المؤلفون: Nicola Silvestris, Caterina Vivaldi, Vincenzo Dadduzio, Luca Faloppi, Giovanni Gerardo Cardellino, Fabio Conti, Giulia Orsi, Mario Scartozzi, Giulia Rovesti, Laura Gramantieri, Lorenzo Fornaro, Matteo Canale, Emiliano Tamburini, Andrea Casadei-Gardini, Francesco Giuseppe Foschi, Giorgia Marisi, Britt Rudnas, Paola Ulivi, Vittorina Zagonel, Luca Ielasi, Francesca Fornari, Mario Domenico Rizzato, Marianna Silletta, Stefano Cascinu, Sara Lonardi

المساهمون: Casadei Gardini, A, Marisi, G, Dadduzio, V, Gramantieri, L, Faloppi, L, Ulivi, P, Foschi, Fg, Tamburini, E, Vivaldi, C, Rizzato, Md, Ielasi, L, Canale, M, Conti, F, Rudnas, B, Fornaro, L, Silvestris, N, Silletta, M, Cardellino, Gg, Lonardi, S, Fornari, F, Orsi, G, Rovesti, G, Zagonel, V, Cascinu, S, Scartozzi, M, Casadei-Gardini A, Marisi G, Dadduzio V, Gramantieri L, Faloppi L, Ulivi P, Giuseppe Foschi F, Tamburini E, Vivaldi C, Domenico Rizzato M, Ielasi L, Canale M, Conti F, Rudnas B, Fornaro L, Silvestris N, Silletta M, Cardellino G, Lonardi S, Fornari F, Orsi G, Rovesti G, Zagonel V, Cascinu C, Scartozzi M

مصطلحات موضوعية: Sorafenib, Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Oral treatment, Nitric Oxide Synthase Type III, Drug Resistance, Single-nucleotide polymorphism, Angiopoietin-2, 03 medical and health sciences, Young Adult, 0302 clinical medicine, Internal medicine, medicine, 80 and over, Humans, In patient, Progression-free survival, Prospective Studies, Polymorphism, Genotyping, Aged, Neoplasm Staging, business.industry, Carcinoma, Liver Neoplasms, Retrospective cohort study, Hepatocellular, Single Nucleotide, Middle Aged, medicine.disease, Prognosis, Progression-Free Survival, 030220 oncology & carcinogenesis, Hepatocellular carcinoma, Aged, 80 and over, Carcinoma, Hepatocellular, Drug Resistance, Neoplasm, Female, Polymorphism, Single Nucleotide, NOS3, ANGPT2, Gene Polymorphisms, HCC, sorafenib, Neoplasm, 030211 gastroenterology & hepatology, business, NOS3 and ANGPT2 Gene, medicine.drug

وصف الملف: ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebc4bc81103117fe993d7889a3b41c86Test

المؤلفون: Hyung-Don Kim, Caterina Vivaldi, Francesca Salani, Martina Valgiusti, Ilario Giovanni Rapposelli, Changhoon Yoo, Stefano Cascinu, Yeonghak Bang, Baek-Yeol Ryoo, Min-Hee Ryu, Giovanni Luca Frassineti, Sook Ryun Park, Valentina Burgio, Sara Lonardi, Mario Domenico Rizzato, Margherita Rimini, Valentina Massa, Mario Scartozzi, Andrea Casadei-Gardini, Vittorina Zagonel

المساهمون: Bang, Y., Yoo, C., Lonardi, S., Kim, H. -D., Vivaldi, C., Rimini, M., Frassineti, G. L., Park, S. R., Rizzato, M. D., Ryu, M. -H., Salani, F., Rapposelli, I. G., Ryoo, B. -Y., Zagonel, V., Massa, V., Valgiusti, M., Burgio, V., Scartozzi, M., Cascinu, S., Casadei-Gardini, A.

المصدر: Targeted Oncology. 16:401-410

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Sorafenib, Cancer Research, medicine.medical_specialty, Carcinoma, Hepatocellular, Pyridines, Population, Placebo, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, Regorafenib, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Pharmacology (medical), Propensity Score, education, Survival analysis, Retrospective Studies, Univariate analysis, education.field_of_study, business.industry, Phenylurea Compounds, Liver Neoplasms, Retrospective cohort study, digestive system diseases, 030104 developmental biology, chemistry, 030220 oncology & carcinogenesis, Propensity score matching, Female, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9312ec95c91c2712f7170314a68430a0Test
https://doi.org/10.1007/s11523-021-00797-3Test

المؤلفون: Valentina Massa, Laura Riggi, Enrico Vasile, Laura Bernardini, Andrea Casadei-Gardini, Lorenzo Fornaro, Monica Lencioni, Caterina Vivaldi, Giovanni Ilario Rapposelli, Irene Pecora, Kalliopi Andrikou, Vincenzo Formica, Francesca Salani, Alfredo Falcone, Silvia Catanese, Giulia Rovesti

المساهمون: Vivaldi, C., Salani, F., Rovesti, G., Pecora, I., Catanese, S., Casadei Gardini, A., Massa, V., Bernardini, L., Riggi, L., Andrikou, K., Rapposelli, G. I., Formica, V., Lencioni, M., Falcone, A., Vasile, E., Fornaro, L.

المصدر: European Journal of Cancer. 137:108-116

مصطلحات موضوعية: Male, 0301 basic medicine, Antimetabolites, Antineoplastic, Cancer Research, medicine.medical_specialty, Paclitaxel, First line, Population, Elderly, First-line chemotherapy, Gemcitabine, Metastatic pancreatic cancer, Nab-paclitaxel, Deoxycytidine, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Older patients, Albumins, Internal medicine, Humans, Medicine, Neoplasm Metastasis, education, Aged, Aged, 80 and over, Response rate (survey), education.field_of_study, business.industry, Pancreatic Neoplasms, Clinical trial, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Female, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5978929f83526f29d05ce29678cee4c5Test
https://doi.org/10.1016/j.ejca.2020.06.031Test

المؤلفون: Caterina Vivaldi, Giulia Bartolini, Giovanni Luca Frassineti, Andrea Casadei-Gardini, Alessandro Cucchetti, Valentina Massa, Ilario Giovanni Rapposelli, Alessandro Passardi, Laura Bernardini

المساهمون: Rapposelli I.G., Casadei-Gardini A., Vivaldi C., Bartolini G., Bernardini L., Passardi A., Frassineti G.L., Massa V., Cucchetti A.

المصدر: Biomolecules, Vol 11, Iss 780, p 780 (2021)
Biomolecules
Volume 11
Issue 6

مصطلحات موضوعية: Oncology, Male, FOLFIRINOX, medicine.medical_treatment, Leucovorin, Biochemistry, Deoxycytidine, 0302 clinical medicine, metastatic pancreatic cancer, Antineoplastic Combined Chemotherapy Protocols, Medicine, Neoplasm Metastasis, Hazard ratio, Middle Aged, QR1-502, Neoplasm Metastasi, Oxaliplatin, Survival Rate, 030220 oncology & carcinogenesis, Vomiting, 030211 gastroenterology & hepatology, Female, Fluorouracil, medicine.symptom, medicine.drug, Human, Adult, medicine.medical_specialty, Paclitaxel, Anemia, matching-adjusted indirect comparison, Irinotecan, Microbiology, Article, Disease-Free Survival, 03 medical and health sciences, Internal medicine, first-line therapy, Humans, Molecular Biology, Aged, Chemotherapy, Antineoplastic Combined Chemotherapy Protocol, business.industry, Retrospective cohort study, medicine.disease, First-line therapy, Matching-adjusted indirect comparison, Metastatic pancreatic cancer, Pancreatic Neoplasms, Gemcitabine, Confidence interval, business

وصف الملف: application/pdf; STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::958f88b342d0aa503056c2fa0a503fc1Test
https://www.mdpi.com/2218-273X/11/6/780Test

المؤلفون: Margherita Rimini, Antonella Argentiero, Giulia Bartolini, Oronzo Brunetti, Nicola Silvestris, Giovanni Luca Frassineti, Andrea Casadei-Gardini, Elisa Sperti, Giulia Rovesti, Laura Bernardini, Francesco Giovannelli, Rosa La Face, Roberto Filippi, Caterina Vivaldi, Giacomo Aimar, Martina Valgiusti, Ilario Giovanni Rapposelli, Luca Aldrighetti, Virginia Quarà, Stefano Cascinu, Elisabetta Fenocchio, Francesco Leone, Silvia Cesario, Francesca Ratti, Lorenzo Fornaro, Kalliopi Andrikou

المساهمون: Casadei-Gardini, A., Filippi, R., Rimini, M., Rapposelli, I. G., Fornaro, L., Silvestris, N., Aldrighetti, L., Aimar, G., Rovesti, G., Bartolini, G., Vivaldi, C., Brunetti, O., Sperti, E., La Face, R., Ratti, F., Andrikou, K., Valgiusti, M., Bernardini, L., Argentiero, A., Fenocchio, E., Frassineti, G. L., Cesario, S., Giovannelli, F., Quara, V., Leone, F., Cascinu, S.

مصطلحات موضوعية: Male, Cancer Research, medicine.medical_specialty, Disease-free survival, medicine.medical_treatment, Biliary tract cancer, Chemotherapy, Cholangiocarcinoma, Gallbladder cancer, Metfromin, Vitamin D, Bile Duct Neoplasms, Female, Follow-Up Studies, Humans, Hypoglycemic Agents, Metformin, Prognosis, Retrospective Studies, Survival Rate, Vitamins, Internal medicine, medicine, Vitamin D and neurology, In patient, Prospective cohort study, Aspirin, business.industry, Vitamin D intake, General Medicine, medicine.disease, Oncology, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38bce34a0a87c1a7f9d8a8e95f8a46ddTest

المؤلفون: Irene Bergna, Giovanni Brandi, Francesco Tovoli, Gianluca Masi, Francesco Di Clemente, Carlo Messina, Giuseppe Cabibbo, Massimo Iavarone, Fabio Piscaglia, Lorenza Rimassa, Tiziana Pressiani, Vincenzo Dadduzio, Stefania De Lorenzo, Piera Federico, Bruno Daniele, Ingrid Garajová, Franco Trevisani, Caterina Vivaldi, Sara Pini, Maria Pia Brizzi, Mario Domenico Rizzato, Claudia Campani, Alessandro Granito, Fabio Marra, Vittorina Zagonel

المساهمون: Tovoli F., Dadduzio V., De Lorenzo S., Rimassa L., Masi G., Iavarone M., Marra F., Garajova I., Brizzi M.P., Daniele B., Trevisani F., Messina C., Di Clemente F., Pini S., Cabibbo G., Granito A., Rizzato M.D., Zagonel V., Brandi G., Pressiani T., Federico P., Vivaldi C., Bergna I., Campani C., Piscaglia F.

المصدر: Liver Cancer
Liver Cancer, Vol 10, Iss 4, Pp 370-379 (2021)

مصطلحات موضوعية: Oncology, Sorafenib, medicine.medical_specialty, Cabozantinib, Hepatocellular carcinoma, Context (language use), chemistry.chemical_compound, Internal medicine, Outcome, Tyrosine kinase inhibitors, medicine, Adverse effect, RC254-282, Settore MED/12 - Gastroenterologia, Original Paper, Hepatology, Performance status, business.industry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, Clinical trial, chemistry, Liver function, business, medicine.drug

وصف الملف: ELETTRONICO; STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c30ffb0cfd2b26ba1bebc28e57750e32Test
http://hdl.handle.net/11568/1107002Test